Lung Cancer Trial, Recruiting NCT05498064 Sponsor: Peking Union Medical College Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT05498064
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with advanced non-small cell lung cancer (a specific type of lung cancer) confirmed through a lab test of a tissue or cell sample, at stage 3b or stage 4.
  • People whose lung cancer has tested positive for a specific gene change called ALK, confirmed through one of several approved lab tests.
  • People whose cancer has continued to grow or spread during or after treatment with a type of medication that targets the ALK gene (known as an ALK-TKI).
  • People who are reasonably well and able to carry out daily activities, as measured by a standard medical scale (rated 0–2 out of 5), and who are expected to live for more than 3 months.
  • People who have cancer that has spread to areas such as bones, the lungs, or the adrenal glands, and who need radiation therapy or are suitable to receive it.
  • People who are able to have standard blood and urine tests done as part of screening before joining the trial.
  • People who agree to either avoid sexual activity or use two reliable forms of contraception during the treatment period and for 90 days after the last dose of the trial medication (this applies to both men and women).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • No exclusion criteria were listed in the official trial record. (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
13 May 2022
Est. completion
31 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression free survival (PFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov